阿尼製藥 ANIP 深 滬
已收盤 04-02 16:00:00 美东时间
74.21
-1.750
-2.30%
華盛通- 最 高76.265
- 今 開75.10
- 成交量 27.58万股
- 最 低 74.21
- 昨 收 75.96
- 總市值 16.64亿
- 52周最高 99.50
- 市盈率 靜 22.32
- 換手率 1.23%
- 52周最低 56.71
- 委 比 12.32%
- 總股本 2242.50万
- 歷史最高 99.50
- 量 比 1.03
- 振 幅 2.71%
- 歷史最低 0.80
- 每 手 1
- 風險率 11.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多财报速睇 | 阿尼制药 2025财年年度营收8.83亿美元，同比增长81.3%；归母净利润0.77亿美元，扭亏为盈
华盛资讯3月3日讯，阿尼制药公布2025财年年度业绩，公司年度营收8.83亿美元，同比增长81.3%，归母净利润0.77亿美元，扭亏为盈。
03-03 20:18
ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50%
ANI Pharma beats Q4 estimates, swings to profit, and sees over $1 billion in 2026 sales as Rare Disease revenue surges 50%.
02-27 22:46
BUZZ-ANI Pharma rises after quarterly results beat estimates
BUZZ-ANI Pharma rises after quarterly results beat estimates ** Shares of drugmaker ANI Pharmaceuticals ANIP.O rise nearly 2% to $78.68 premarket ** Co posts Q4 adjusted profit of $2.33 per share, compared to analysts' estimate of $2 per share, according to data compiled by LSEG ** Posts Q4 revenue
02-27 21:53
财报速睇 | 阿尼制药 2025财年年度营收8.83亿美元，同比增长43.8%；归母净利润0.77亿美元，扭亏为盈
华盛资讯2月27日讯，阿尼制药公布2025财年年度业绩，公司年度营收8.83亿美元，同比增长43.8%，归母净利润0.77亿美元，扭亏为盈。
02-27 20:34
ANI Pharma Q4 profit beats on rare disease, generics growth; reaffims forecast
ANI Pharma Q4 profit beats on rare disease, generics growth; reaffims forecast Overview Biopharmaceutical firm's Q4 revenue grew 29.6% yr/yr, driven by Rare Disease and Generics Adjusted EPS for Q4 beat analyst expectations Company plans expansion of Rare Disease organization by ~90 people in 2026 O
02-27 19:59
ANI Pharmaceuticals Q4 Adj. EPS $2.33 Beats $2.00 Estimate, Sales $247.060M Beat $231.534M Estimate
ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $2.33 per share which beat the analyst consensus estimate of $2.00 by 16.79 percent. This is a 42.94 percent increase over earnings of $1.63 per share from
02-27 19:59
Earnings Scheduled For February 27, 2026
Companies Reporting Before The Bell • Escalade (NASDAQ:ESCA) is estimated to re...
02-27 19:11
A Look Ahead: ANI Pharmaceuticals's Earnings Forecast
ANI Pharmaceuticals (NASDAQ:ANIP) is preparing to release its quarterly earning...
02-26 23:01
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
ANI Pharmaceuticals to Present at Upcoming Investor Conferences ANI Pharmaceuticals Inc. said CEO Nikhil Lalwani and other executives will present at upcoming investor conferences: Raymond James & Associates’ 47th Annual Institutional Investors Conference on March 3, 2026 at 7:30 a.m. ET; the Leerin
02-24 19:50
